Sperm changes documented years after chemotherapy

February 1, 2017
Human sperm stained for semen quality testing in the clinical laboratory. Credit: Bobjgalindo/Wikipedia

A Washington State University researcher has documented epigenetic changes in the sperm of men who underwent chemotherapy in their teens.

The changes can influence how genes are turned on an off, potentially affecting the health of tissues in subsequent generations, said Michael Skinner, a professor in the WSU School of Biological Sciences and Center for Reproductive Biology. He is suggesting that teens about to undergo have some of their sperm preserved for when they would like to start a family.

"I'm not suggesting that you shouldn't use chemo," he said. "In fact, I would suggest that you probably should use the chemo. I'm just saying that there are some preventative things that may need to be put in place before you use the chemo if possible."

Skinner is a leading expert in the field of epigenetics, which looks at changes in how genetic information is passed between generations. While certain environmental exposures can leave DNA sequences unaffected, he has documented how epigenetic change—alterations of small chemical groups attached to the DNA—affects how genes are turned on and off. His earlier work has found epigenetic effects from a host of environmental toxicants, connecting plastics, pesticides, fungicide, dioxin and hydrocarbons to diseases and abnormalities as many as four generations later.

Reproducible pattern of molecular changes

For the current study, published Wednesday in the online journal PLOS One, Skinner collaborated with researchers at the Seattle Children's Research Institute and the Fred Hutchinson Cancer Research Center. They include colleague Margarett Shnorhavorian, surgical director of the differences in sex development program at Seattle Children's and associate professor of urology at the University of Washington.

She obtained sperm from 18 men who had undergone chemotherapy as adolescents and 18 untreated men whose sperm served as a control.The sample size was small, Skinner acknowledged, but all the sperm from the former chemotherapy patients had a similar pattern of .

"It was very reproducible," he said. "That in and of itself was very surprising to me."

Next step: Effects in offspring

Direct exposure to chemotherapy could affect a lot of cells, Skinner said, but those effects should have disappeared within months. The testes take 75 days to make , which remains in the body for 20 or 30 more days. So for effects to be seen 10 years later, cells in the testes must be "permanently altered," he said.

Skinner and his colleagues plan to investigate what effects, if any, these changes are having on subsequent generations. Shnorhavorian has received funding to look at the epidemiology of and their offspring, and Skinner hopes to look at similar changes in rodents.

Previous rodent studies have seen epigenetic alterations leading to prostate and breast cancers, kidney disease and decreases in male and female fertility in second and third generations, Skinner said.

"Those are things that I would predict, but I have no idea in this situation if that's the case," he said.

Skinner is founder of the WSU Center for Reproductive Biology. His groundbreaking work has been highlighted in documentaries by the BBC, Smithsonian and PBS. He became a member of the American Association for the Advancement of Science in 2012 and received a Smithsonian Ingenuity award in 2013.

Explore further: Researchers investigate effect of environmental epigenetics on disease and evolution

More information: PLOS One, journals.plos.org/plosone/arti … journal.pone.0170085

Related Stories

Researchers investigate effect of environmental epigenetics on disease and evolution

August 3, 2015
Washington State University researchers say environmental factors are having an underappreciated effect on the course of disease and evolution by prompting genetic mutations through epigenetics, a process by which genes are ...

Dioxin causes disease and reproductive problems across generations

September 26, 2012
Since the 1960s, when the defoliant Agent Orange was widely used in Vietnam, military, industry and environmental groups have debated the toxicity of its main ingredient, the chemical dioxin, and how it should be regulated.

Effects of environmental toxicants reach down through generations

March 2, 2012
A Washington State University researcher has demonstrated that a variety of environmental toxicants can have negative effects on not just an exposed animal but the next three generations of its offspring.

Environmental toxicants causing ovarian disease across generations

May 4, 2012
Washington State University researchers have found that ovarian disease can result from exposures to a wide range of environmental chemicals and be inherited by future generations.

DDT and obesity linked in new study

October 22, 2013
Washington State University researchers say ancestral exposures to environmental compounds like the insecticide DDT may be a factor in high rates of obesity. The finding comes as DDT is getting a second look as a tool against ...

Plastic products and jet fuel exposures raising incidences of 'epigenetic transgenerational inheritance'

January 24, 2013
Washington State University researchers have lengthened their list of environmental toxicants that can negatively affect as many as three generations of an exposed animal's offspring.

Recommended for you

Combination immunotherapy targets cancer resistance

November 22, 2017
Cancer immunotherapy drugs have had notable but limited success because in many cases, tumors develop resistance to treatment. But researchers at Yale and Stanford have identified an experimental antibody that overcomes this ...

Researchers discover specific tumor environment that triggers cells to metastasize

November 21, 2017
A team of bioengineers and bioinformaticians at the University of California San Diego have discovered how the environment surrounding a tumor can trigger metastatic behavior in cancer cells. Specifically, when tumor cells ...

New study points the way to therapy for rare cancer that targets the young

November 21, 2017
After years of rigorous research, a team of scientists has identified the genetic engine that drives a rare form of liver cancer. The findings offer prime targets for drugs to treat the usually lethal disease, fibrolamellar ...

Clinical trial suggests new cell therapy for relapsed leukemia patients

November 20, 2017
A significant proportion of children and young adults with treatment-resistant B-cell leukemia who participated in a small study achieved remission with the help of a new form of gene therapy, according to researchers at ...

Cell-weighing method could help doctors choose cancer drugs

November 20, 2017
Doctors have many drugs available to treat multiple myeloma, a type of blood cancer. However, there is no way to predict, by genetic markers or other means, how a patient will respond to a particular drug. This can lead to ...

Researchers discover a new target for 'triple-negative' breast cancer

November 20, 2017
So-called "triple-negative" breast cancer is a particularly aggressive and difficult-to-treat form. It accounts for only about 10 percent of breast cancer cases, but is responsible for about 25 percent of breast cancer fatalities.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.